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Background: This study aimed to evaluate real-time polymerase chain reaction coupled
with multiplex probemelting curve analysis (PCR-MCA) for pathogen detection in patients
with suspected bloodstream infections (BSIs).
Methods: A PCR-MCA assay was developed for simultaneous identification of 28 kinds
of the most common pathogens and two resistance genes within a few hours. The
diagnostic performance of the PCR-MCA assay was determined and compared to the
results of blood culture.
Results: A total of 2,844 consecutive new episodes of suspected BSIs in 2,763 patients
were included in this study. There were 269 episodes of pathogens identified by blood
culture. For all the pathogens tested, the PCR-MCA assay exhibited a sensitivity of 88.8%
(239/269), specificity of 100% (2,575/2,575), and agreement of 98.9% (2,814/2,844). For
the pathogens on the PCR-MCA list, the PCR-MCA results had a sensitivity of 99.2%
(239/241), specificity of 100% (2,575/2,575), and agreement of 99.9% (2,814/2,816)
compared with the results of blood culture. For seven samples with multiple pathogens
identified simultaneously during one blood culture investigation, the PCR-MCA assay
verified the results of the blood culture, with an agreement rate of 100% for each.
Conclusion: The PCR-MCA assay could discover 88.8% of the pathogens in clinical
practice, showing excellent diagnostic performance vs. that of blood culture for pathogen
detection in patients with suspected BSIs, and would contribute to rapid diagnosis and
correct antibiotic administration.
Keywords: PCR-MCA, bloodstream infections, pathogen detection, diagnostic performance, blood culture
INTRODUCTION
Sepsis could be called a severe complication of bloodstream infections (BSIs). The reported
incidence of sepsis is increasing, and conservative estimates indicate that sepsis is a leading cause of
mortality and critical illness worldwide (Singer et al., 2016). Early recognition of sepsis and accurate
administration of antibiotics are important for improving outcomes. According to international
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guidelines (Singer et al., 2016), empirical antibiotic treatment
should be given within 1 h once sepsis is suspected, and broad-
spectrum antibiotics are often recommended. However,
as early empirical treatment may be ineffective more
often than in the past because of the worldwide rise and
broadening of bacterial multidrug resistance (Gustinetti
and Mikulska, 2016), precise diagnosis and antibiotic
treatment targeting the causative pathogen of sepsis are
urgently need.
Blood cultures, aiming to detect viable microorganisms
in blood, are still considered as the “gold standard” for
the microbiological diagnosis of BSIs. Suspected BSIs can be
identified if the culture is obtained first and the antibiotic is
concomitantly administered within 72 h, whereas if the antibiotic
is first and the culture is acquired within 24 h (Singer et al.,
2016). However, when antibiotics are administered before the
culture is obtained, sensitivity is greatly reduced, and slow-
growing, fastidious microorganisms are difficult to detect by
blood culture (Opota et al., 2015). Studies have shown that
only approximately half of the patients experiencing sepsis and
septic shock have positive blood cultures (Bochud et al., 2001).
Furthermore, ∼24–72 h is required to identify the pathogen
and obtain information on antibiotic sensitivity (Peters et al.,
2004). As a consequence, empirical antibiotic therapy is more
commonly guided by clinical response than by the result of a
blood culture.
To achieve faster and more accurate diagnosis of sepsis,
rapid molecular diagnostic tests have been developed for BSI
diagnosis. The U.S. Food and Drug Administration has cleared
several multiplex molecular assays that can detect a wide range
of microorganisms concurrently with specific resistance genes
directly in blood samples, and some of these assays have been
made commercially available (Rello et al., 2018). One of the
most developed technologies is the multiplex polymerase chain
reaction (PCR) assay, which can detect the DNA of as many
as 20 pathogen species directly in blood samples within hours
(Galiana et al., 2017; Makristathis et al., 2018), even more kinds
of microorganisms concurrently with several resistance genes
in positive blood cultures (Ramanan et al., 2018). Recently,
multiplex probe melting curve analysis (MCA) based on real-
time PCR assays has also been applied in pathogen identification
(Jiang et al., 2017), allowing simultaneous identification of ten
bacterial pathogens in gastroenteritis and wound infections
via a single reaction. On this basis, we developed a real-time
PCR coupled with multiplex probe MCA (PCR-MCA) assay for
simultaneous identification of 28 kinds of the most common
pathogens and two resistance genes in BSIs. After the multiplex
ligation reaction, linear-after-the-exponential PCR was carried
out with a real-time PCR instrument by using the fluorophore
and melting temperature (Tm) value as dual indicators, and
MCA yielded a unique Tm code by which a certain pathogenic
bacterium could be identified (Liao et al., 2013). In this study, we
aimed to evaluate the clinical performance of this assay compared
with that of blood culture for pathogen detection in patients with
suspected BSIs.
MATERIALS AND METHODS
Study Population and Ethics Statement
This study was conducted at Zhongshan Hospital, School of
Medicine, Xiamen University, from October 2016 to June 2017.
The inclusion criteria for the study population were as follows:
clinical suspicion of the development of life-threatening organ
dysfunction caused by a BSI identified by a treating clinician and
an urgent need for blood cultures. For clinical operationalization,
organ dysfunction can be represented by an increase of 2 points
or more in the sepsis-related organ failure assessment score
(Singer et al., 2016). Patients who had been administered with
antibiotics (such as some postoperative or transferred patients)
were excluded from the study. In this study, the observation
unit was an episode of suspected BSI, the results were evaluated
as follows: once a bacterial or fungal pathogen was isolated
from at least one blood culture, a positive BSI episode was
recorded, and the consecutive duplicate results were merged; a
BSI episode was considered new if it was detected at least 14
days from the previous infection with positive blood culture
or if a different microorganism was isolated from a new blood
sample (Quiles et al., 2019); consecutive repeated negative blood
culture results from one patient during one hospitalization was
recorded as a negative BSI episode. A total of 2,763 patients
with 2,844 consecutive new episodes of suspected BSIs were
recruited. This study was approved by the Institutional Ethics
Committee of Zhongshan Hospital, School of Medicine, Xiamen
University, and was in compliance with national legislation and
the Declaration of Helsinki guidelines. Written informed consent
was obtained from the patient or, from next of kin or an
independent patient advocate if the patient lacked this capacity.
Laboratory Procedures
Blood samples were obtained from eligible patients as follows.
First, two blood samples were collected simultaneously from
peripheral venepuncture (8–10mL for adults and 1mL for
children) and inoculated into paired culture bottles (Plus
Aerobic, Plus Anaerobic; BD BACTECTM). Blood culture entered
the standard clinical pathway, and the results were returned
directly to the clinical service at each center. Second, research
blood samples (5mL for adults and 1mL for children) were
obtained from the same venepuncture sites at the same time and
were placed into sterile EDTA tubes for PCR-MCA analysis of
pathogen DNA in whole blood. The research blood samples were
transferred to a single molecular laboratory and kept for no more
than 72 h at 4◦C prior to PCR analysis.
Blood Culture
Blood culture bottles were incubated for 5 days in an automated
blood culture instrument (BD BactecTM FX). When bacterial
growth was noted, the positive culture sample was inoculated
into blood agar, MacConkey agar and chocolate agar and
then cultured overnight in a 37◦C electro-heating standing-
temperature cultivator. A single colony of fresh overnight culture
was smeared directly onto a ground-steel matrix-assisted laser
desorption/ionization (MALDI) target plate, covered with 1.5
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µL of saturated α-cyano-4-hydroxycinnamic acid matrix in
50% acetonitrile-2.5% trifluoroacetic acid and allowed to dry.
The plate was inserted into the source of a Bruker Microflex
LT/SH MALDI-TOF-MS instrument (Bruker MALDI Biotyper)
for identification. The blood culture was considered negative if
no bacterial growth was detected within 5 days and was not
evaluated by the Bruker MALDI Biotyper.
DNA Preparation
The blood was cultured with a pipette at 1mL in an EP tube and
centrifuged at 13,000 × g for 2min to precipitate the bacteria.
After the supernatant was removed by pipetting, 100 µL of 1 ×
TE buffer (10mM Tris base, 1mM EDTA, pH 8.5) was added
to the bacterial precipitate. The EP tube was heated at 99◦C for
10min and centrifuged at 13,000× g for 10min. The supernatant
was removed into the new EP tube and stored in a−20◦C freezer
for PCR-MCA.
PCR-MCA
In this study, tagged primers were used, which were different
from universal primers in that they contained a common tag
sequence at the 5′ ends of specific primers. The primer sequences
(Sangon Biotech (Shanghai) Co., Ltd.) are shown in Table 1;
these primers target 12 kinds of gram-positive bacteria, 11
kinds of gram-negative bacteria, five kinds of fungi, and two
resistance genes, namely, a vancomycin resistance-encoding gene
for Enterococcus species (vanA) and a beta-lactam resistance-
encoding gene for Staphylococcus species (mecA). The probes in
this study were composed of media probes and universal probes.
The secondary structures of the probes were predicted using
mfold Web Server online analysis software (http://mfold.rna.
albany.edu/?q=mfold/DNA-Folding-Form). The fluorophores
FAM, ROX, CY5, and HEX were marked with a 5′ universal
probe, and the quenchers BHQ1 and BHQ2 were marked with
a 3′ probe. The probe sequences have not been shown here as the
patent is pending. The Tm values of the probes were predicted
using Tm Utility v1.3 software. The homology of the designed
primers and probes was tested using BLAST software (https://
blast.ncbi.nlm.nih.gov/Blast.cgi).
When the uniplex PCR assay was established, three pairs
of primers were designed for each testing object first, and
primers were screened by pairwise combination to select the
optimal primer combination. Second, the PCR components were
optimized. The final 25-µL uniplex PCR assay included 5.0mM
MgCl2, 1× buffer (67mM Tris-HCl, 16.6mM (NH4)2SO4,
6.7µM EDTA, and 0.085 mg/mL BSA), 0.2mM dNTPs, 2.0U
of Taq01 DNA polymerase, 0.01U of UNG enzyme, 0.05µM
forward/reverse primers, 0.4µM universal primers, 0.3µM
media probes, 0.08µM universal probes, and 5 µL of template
DNA. After the PCR procedure was optimized, the procedure
used for the uniplex PCR assay for BSIs was as follows:
amplification stage: 50◦C for 2min, predenaturation at 95◦C
for 5min, 95◦C for 20 s and 60◦C for 1min (for a total of
50 cycles), and final extension at 35◦C for 25min; melting
stage: denaturation at 95◦C for 2min and heat preservation at
45◦C for 2min, followed by probe melting curve analysis via
a temperature ramp from 45 to 95◦C with a heating rate of
0.04◦C/s. Fluorescence signals in the corresponding detection
channels were collected during the whole melting process.
On the basis of the uniplex PCR assay for BSIs, all primers and
probes were combined to establish the multiplex PCR assay. The
PCR components were optimized, and the final 25-µL multiplex
PCR assay included 5.0mMMgCl2, 1 × buffer, 0.25mM dNTPs,
2.5U of Taq01 DNA polymerase, 0.01U of UNG enzyme, 0.7µM
universal primers, 7 universal probes at 0.1µM each, and 5 µL
of template DNA. After the PCR procedure was optimized, the
procedure used for themultiplex PCR assay for BSIs was the same
as that for the uniplex PCR assay, and the fluorescence signals in
the corresponding detection channels were collected during the
whole melting process. The uniplex and multiplex experiments
were carried out on an SLAN 96S real-time fluorescence PCR
instrument (Shanghai Hongshi Medical Technology Co., Ltd.).
Discordant results between the PCR-MCA assay and blood
culture were further verified using a uniplex PCR assay.
Analytical Evaluation
To evaluate analytical sensitivity, first, plasmids of 28 kinds of
pathogens and two resistance genes were constructed, and serial
dilutions of the DNA were prepared from 104 copies/µL to 100
copies/µL. Second, suspensions of reference strains of the 28
kinds of pathogens were prepared with serial 10-fold dilutions in
0.9% NaCl. Each dilution, the concentration was determined by
plate counts (CFU/mL), was subjected to DNA extraction. The
limit of detection (LOD) was defined as the lowest concentration
that yielded nomore than one negative result in 20 replicates (i.e.,
positive rate, ≥95%).
To evaluate analytical specificity, each target pathogen or
resistance gene in the detection system was used as a template
for the PCR. In addition, a blind test of the bacterial samples,
including the 28 targeted pathogens and non-targeted pathogens,
was performed.
The reproducibility was evaluated using the constructed
plasmids for each pathogen or resistant gene as templates
(concentration 103 copies/µL). The experiments were carried out
three times on the same instrument, with three duplicates of
each template for each experiment. The Tm values of the melting
peaks of each test object in different experiments and parallel
tubes were analyzed by calculating the standard deviations (SDs)
and coefficient of variation (CV).
Statistical Analysis
The results of blood culture for identification of pathogens
were used as the gold standard in this study. The diagnostic
performance of the PCR-MCA assay was determined and
compared to the results of blood culture, using sensitivity,
specificity, positive predictive value, negative predictive value
(NPV), agreement rate and Kappa value, according to the
Yerushalmy model (Niu et al., 2015). The sensitivity was
calculated as the number of episodes in which both blood culture
and PCR-MCAwere positive divided by the sum of these episodes
and the number of episodes in which blood culture was positive
but PCR-MCA were negative. The specificity was calculated as
the number of episodes in which both blood culture and PCR-
MCA were negative divided by the sum of these episodes and the
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TABLE 1 | Primer sequences for the pathogens in the PCR-MCA system.
Pathogens Primer sequences Tm* (◦C)
Gram negative
Tag GCAACGGGTCAGGTAGCCATCTC
Escherichia coli Forward Tag-ATCGATCCATATTTACCATATCAATACTTG 62.09
Reverse Tag-ATCCAGTATGTTCAAATCCTAAGTTACTC
Klebsiella pneumoniae Forward Tag-GGTAAAATGAGTTTGCCGC 61.21
Reverse Tag-ACCAGGATATTCAGCAGCAT
Acinetobacter baumannii Forward Tag-ATGGTGAAATTCGTGGTAAAGA 69.60
Reverse Tag-GGCGAGATGGTTTACTCACTA
Pseudomonas aeruginosa Forward Tag-CTTGAGGTAGGGACCGAG 81.80
Reverse Tag-CGACGAGCTGTACATGGT
Enterobacter cloacae Forward Tag-TCAGGTAAGTTATTCATCATCATCTTAT 80.61
Reverse Tag-TAAACGCTGGTTTTTTCATAAT
Klebsiella oxytoca Forward Tag-GATCGTCCGAACCCAGCAG 76.06
Reverse Tag-CGGCGGCGAATTCAAAAC
Enterobacter aerogenes Forward Tag-GCGGCAAAGTCCATATATAAACT 67.23
Reverse Tag-AGAAAATCATAGGGATAGCGTAGT
Haemophilus parainfluenzae Forward Tag-CTTTGATGACGAGTGGCGGA –
Reverse Tag-TCCCACTTGGGCTCATCCTA
Citrobacter Forward Tag-CGTGTAACTCTTATCAGAATATCAGC 64.30
Reverse Tag-AAAAACGAGATTATACCGTAACCCT
Serratia marcescens Forward Tag-TTCCTGTTCCTGGAAGAC 67.26
Reverse Tag-GTTCTTGTCGTTTTCCACC
Proteus mirabilis Forward Tag-AGTAAAGAGAACACAGATTGTAA 80.58
Reverse Tag-TCACAGTCACCACTAATCTCAC
Gram positive
Tag GCAACGGGTCAGGTAGCCATCTC
Staphylococcus aureus Forward Tag-ATCGATCCATATTTACCATATCAATACTTG 79.14
Reverse Tag-ATCCAGTATGTTCAAATCCTAAGTTACTC
Staphylococcus epidermidis Forward Tag-CCCCATCTTTTTAAGTGTTTAGGAAT 79.72
Reverse Tag-ATCAGTAATGGGAAATAAATCCATATTGA
Streptococcus pneumoniae Forward Tag-GGTATTGTTGGTTATGTACTTGTGT 75.51
Reverse Tag-ATTTCTCTTTATCTTTTGCTTTGG
Staphylococcus capitis Forward Tag-
GCTGGACTAAAAAGTATAAGAGTATACTGATTA
74.87
Reverse Tag-ATCCAAGTATTTTTCTAATCGCGTATCT
Enterococcus faecalis Forward Tag-GACGAAAGTCTGACCGAGCA –
Reverse Tag-TGCCACCTACGTATTACCGC
Enterococcus faecium Forward Tag-TTGGAATGAAGTTGGCGGGA –
Reverse Tag-GCTGCCGAACAGTTCCTGAT
Streptococcus dysgalactiae Forward Tag-GAAATGGAACACGTTAGGGTCG –
Reverse Tag-TCTTAACTAGAAAAACTCTTGATTATTC
Streptococcus anginosus Forward Tag-GTTTTGCAGAAGCGATTGTC –
Reverse Tag-TGAGAGCACGGTTTGAGTCG
Staphylococcus
haemolyticus
Forward Tag-TGAATCTGGTGGCGACATTAC 75.87
Reverse Tag-AGGAGCTACTGAATCCCAAGTA
Streptococcus mutans Forward Tag-CCTACGGGAGGCAGCAGTAG –
Reverse Tag-CAACAGAGCTTTACGATCCGAAA
Streptococcus pyogenes Forward Tag-CACCTTACTAACTGAACAATCTT 74.52
Reverse Tag-GTGTAGTGGAGGTAGAAGGTT
(Continued)
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TABLE 1 | Continued
Pathogens Primer sequences Tm* (◦C)
Listeria Forward Tag-GCCTTTTTCATTGGTAGCATC 63.82
Reverse Tag-GCAAGGTAGAGGATATAGAGAAG
Fungus
Tag GCAACGGGTCAGGTAGCCATCTC
Candida albicans Forward Tag-GCCATCTAGGAGTAAACCACAAC 59.30
Reverse Tag-CAGCCAGGGTAGCTCATG
Candida glabrata Forward Tag-ATCTAAGGCTAAATACTGGCGA 79.50
Reverse Tag-CAATACCCTTCCCTTTCAACA
Candida parapsilosis Forward Tag-GTCGTGGTCTTCAGTAACTAACA 84.66
Reverse Tag-AAGATTCAGCCAACCACAAGATG
Candida krusei Forward Tag-CTCGGAATGTATCACCTCT 82.08
Reverse Tag-TTTACGACCATTACGCCAG
Aspergillus fumigatus Forward Tag-ATCAGTATGTGGGACACGAG 69.45
Reverse Tag-CGAGTTGGTAAAACCTAATACAGT
Resistance gene
Tag GCAACGGGTCAGGTAGCCATCTC
mecA Forward Tag-GTGATTATCCATTTTATAATGCTCA 85.19
Reverse Tag-GCCATTATTTTCTAATGCGCTAT
vanA Forward Tag-GGTGTATGGAAAATGTGCGAA 74.44
Reverse Tag-GGCGAGAGTACAGCTGAATAG
Internal control
Forward GCCATCTCTCTCTATTAGTTCGT 70.91
Reverse GCCATCTCTCTCTATTAGTTCGT
PCR-MCA, real-time polymerase chain reaction coupled with multiplex probe melting curve analysis; vanA, vancomycin resistance-encoding gene for Enterococcus species; mecA,
beta-lactam resistance-encoding gene for Staphylococcus species.
*The Tm values for Haemophilus parainfluenzae, Enterococcus faecalis, Enterococcus faecium, Streptococcus dysgalactiae, Streptococcus anginosus, and Streptococcus mutans are
not shown because the patent is pending.
number of episodes in which blood culture was negative but PCR-
MCAwere positive. The statistical analyses were performed using
SPSS 19.0 for Windows (SPSS Inc., Chicago, Illinois, USA).
RESULTS
Characteristics of the Study Participants
A total of 2,763 patients with 2,844 consecutive new episodes of
suspected BSIs were recruited in this study. The median age of
patient episodes was 44 years (interquartile range, 1–67 years),
including 1,658 male episodes (58.3%) and 1,186 female episodes
(41.7%). The main proportion of participants came from the
pediatrics department (33.5%), followed by the pulmonology
department (16.7%), general surgery department (10.2%),
hematology department (6.6%), gastroenterology department
(6.2%), nephrology department (5.3%), etc (Table 2). The
prevalence of BSIs identified by blood culture was 26.5%
(148/558) in surgery, 7.5% (93/1,248) in internal medicine,
11.9% (10/84) in obstetrics and gynecology, and 1.9% (18/954)
in pediatrics.
Performance of the PCR-MCA Assay for
Identification of Pathogens Compared to
That of Blood Culture
The analytical sensitivity, specificity and reproducibility of the
PCR-MCA assay were evaluated. The results showed that the
analytical sensitivity reached 50 to 5 copies per reaction. The 28
targeted pathogens gave reproducible readouts in 20 replicates
when the concentration was equal to or higher than 300 CFU/mL;
therefore, the PCR-MCA assay LOD was determined to be 300
CFU/mL (data not shown). The analytical specificity results
showed that the PCR-MCA assay could correctly detect all 28
targeted pathogens and exhibited no cross-reactivity with non-
targeted pathogens. The relevant melting signal peak of each
pathogen or resistance gene was achieved, and no interference
existed among the signals. The reproducibility results showed
that the SDs of the Tm values were no more than 1◦C and that
the CVs were no more than 1%, indicating a high reproducibility
of this assay.
Among the 2,844 episodes of suspected BSIs, 269 were
identified for the presence of pathogens with the results of
blood culture. The most common gram-negative pathogen
was Escherichia coli (n = 95, 35.3%), followed by Klebsiella
pneumoniae (n = 40, 14.9%), Acinetobacter baumannii (n =
9, 3.3%), Pseudomonas aeruginosa (n = 9, 3.3%), Enterobacter
cloacae (n = 5, 1.9%), etc. The most common gram-positive
pathogen was Staphylococcus aureus (n = 22, 8.2%), followed
by Staphylococcus epidermidis (n = 16, 5.9%), Streptococcus
pneumoniae (n = 9, 3.3%), Staphylococcus capitis (n = 7, 2.6%),
Enterococcus faecium (n = 6, 2.2%), Enterococcus faecalis (n =
6, 2.2%), etc. The most common fungus was Candida albicans
(n = 8, 3.0%). Among the 2,844 episodes of suspected BSIs, 24
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episodes were identified with Staphylococcus species (including
11 with S. epidermidis, five with S. capitis, four with S. aureus,
two with S. haemolyticus, one with S. hominis, and one with S.
lugdunensis) resistant to all beta-lactam antibiotics in phenotypic
susceptibility tests. However, the mecA gene was not detected
in any of these species using the PCR-MCA assay. In addition,
no vancomycin-resistant Enterococcus species were identified
in phenotypic susceptibility tests, consistent with the PCR-
MCA result showing that the vanA gene was not detected. The
performance of the PCR-MCA assay compared to that of blood
culture for identification of each pathogen is shown in Table 3.
For all the pathogens tested, the PCR-MCA assay discovered
88.8% (239/269) of the pathogens discovered by blood culture,
with a sensitivity of 88.8%, specificity of 100% (2,575/2,575), and
agreement of 98.9% (2,814/2,844). Among the 269 episodes of
pathogens identified by blood culture, 241 were identified with
a pathogen on the PCR-MCA list, while 28 were not. For the
pathogens on the PCR-MCA list, the PCR-MCA assay had a
sensitivity of 99.2% (239/241), specificity of 100% (2,575/2,575),
and agreement of 99.9% (2,814/2,816) compared with the results
of blood culture.
Results of the Blood Culture and
PCR-MCA Assay for the Identification of
Multiple Infections
Among the 2,763 patients recruited, there were seven cases in
whose blood samples two kinds of pathogens were identified
simultaneously during one blood culture investigation. For these
samples, the PCR-MCA assay verified the results of blood culture,
with an agreement rate of 100% for each case. The results of
blood culture and the PCR-MCA assay for the identification of
multiple infections are shown in Table 4. In addition, there were
eight subjects who underwent two or more sequential episodes
of BSIs at different times during one hospitalization. In five cases
(cases number 10, 82, 91, 94, and 133), the results of the PCR-
MCA assay for identification of pathogens were consistent with
those of blood culture in every infection episode. For case No.
9, the PCR-MCA assay verified the results of blood culture for
the second and third infection episodes but showed negative
results for the first episode, while K. pneumoniae was detected by
blood culture. For case No. 176, the PCR-MCA assay verified the
results of blood culture for the first infection episode but showed
negative results for the second and third episodes because the
pathogens identified by blood culture were not on the PCR-MCA
list. For case No. 334, the result of the PCR-MCA assay was the
same as that of blood culture for the first infection episode but
detected one more pathogen than blood culture for the second
infection episode.
Clinical Characteristics of Patients With
Discordant Results Between Blood Culture
and the PCR-MCA Assay
Among the 2,844 episodes of suspected BSIs, there were eight
episodes from eight cases for which the results of the PCR-MCA
assay were inconsistent with those of blood culture. The clinical
characteristics of these cases are shown in Table 5. Two cases
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TABLE 3 | Performance of the PCR-MCA assay for identification of pathogens compared to the results of blood culture.
Pathogens Blood culture/PCR-MCA Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Agreement
rate (%)
Kappa
value
+/+a +/−b −/+c −/−d
Pathogens on the PCR-MCA List
Gram negative
E. coli 95 0 1 2,748 100.00 99.96 99.00 100.00 99.96 0.995
K. pneumoniae 38 2 1 2,803 95.00 99.96 97.40 99.93 99.89 0.961
A. baumannii 9 0 2 2,833 100.00 99.93 81.80 100.00 99.93 0.900
P. aeruginosa 9 0 0 2,835 100.00 100.00 100.00 100.00 100.00 1.000
E. cloacae 5 0 0 2,839 100.00 100.00 100.00 100.00 100.00 1.000
K. oxytoca 2 0 0 2,842 100.00 100.00 100.00 100.00 100.00 1.000
E. aerogenes 2 0 0 2,842 100.00 100.00 100.00 100.00 100.00 1.000
H. parainfluenzae 1 0 0 2,843 100.00 100.00 100.00 100.00 100.00 1.000
Citrobacter 1 0 0 2,843 100.00 100.00 100.00 100.00 100.00 1.000
S. marcescens 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
P. mirabilis 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
Gram positive
S. aureus 22 0 0 2,822 100.00 100.00 100.00 100.00 100.00 1.000
S. epidermidis 16 0 0 2,828 100.00 100.00 100.00 100.00 100.00 1.000
S. pneumoniae 9 0 1 2,834 100.00 99.96 90.00 100.00 99.96 0.947
S. capitis 7 0 0 2,837 100.00 100.00 100.00 100.00 100.00 1.000
E. faecium 6 0 0 2,838 100.00 100.00 100.00 100.00 100.00 1.000
E. faecalis 6 0 1 2,837 100.00 99.96 85.70 100.00 99.96 0.923
S. dysgalactiae 3 0 0 2,841 100.00 100.00 100.00 100.00 100.00 1.000
S. anginosus 3 0 0 2,841 100.00 100.00 100.00 100.00 100.00 1.000
S. haemolyticus 2 0 0 2,842 100.00 100.00 100.00 100.00 100.00 1.000
S. mutans 1 0 0 2,843 100.00 100.00 100.00 100.00 100.00 1.000
S. pyogenes 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
L. monocytogenes 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
Fungus
C. albicans 8 0 0 2,836 100.00 100.00 100.00 100.00 100.00 1.000
C. glabrata 1 0 0 2,843 100.00 100.00 100.00 100.00 100.00 1.000
C. parapsilosis 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
C. krusei 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
A. fumigatus 0 0 0 2,844 n.a. 100.00 n.a. 100.00 100.00 n.a.
Pathogens not on the PCR-MCA List
Streptococcus constellatus 0 4 0 2,840 0.00 100.00 n.a. 99.86 99.86 n.a.
Burkholderia cepacia 0 3 0 2,841 0.00 100.00 n.a. 99.89 99.89 n.a.
Bacteroides fragilis 0 2 0 2,842 0.00 100.00 n.a. 99.93 99.93 n.a.
Salmonella typhimurium 0 2 0 2,842 0.00 100.00 n.a. 99.93 99.93 n.a.
Staphylococcus hominis 0 2 0 2,842 0.00 100.00 n.a. 99.93 99.93 n.a.
Streptococcus mitis 0 2 0 2,842 0.00 100.00 n.a. 99.93 99.93 n.a.
Aeromonas hydrophila 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Atopobium 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Clostridium difficile 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Corynebacterium striatum 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Enterococcus avium 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Enterococcus casselifavus 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Kingella denitrificans 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Micrococcus 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Non-fermenter 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Staphylococcus cohnii 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Staphylococcus lugdunensis 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Stenotrophomonas maltophilia 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
Streptococcus intermedius 0 1 0 2,843 0.00 100.00 n.a. 99.96 99.96 n.a.
PCR-MCA, real-time polymerase chain reaction coupled with multiplex probe melting curve analysis; PPV, positive predictive value; NPV, negative predictive value; n.a., not applicable.
a
+/+ represents the number of episodes in which both blood culture and PCR-MCA were positive.
b
+/− represents the number of episodes in which blood culture was positive but PCR-MCA was negative.
c
−/+ represents the number of episodes in which blood culture was positive but PCR-MCA was negative.
d
−/− represents the number of episodes in which both blood culture and PCR-MCA were negative.
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TABLE 4 | Results of blood culture and the PCR-MCA assay for the identification of multiple infections.
Patient Date Time-to-positivity of blood culture (hours) Blood culture PCR-MCA
Pathogen 1 Pathogen 2 Pathogen 1 Pathogen 2
Simultaneous multiple infections during one blood culture investigation
3 2016/10/15 23.0 E. faecalis Citrobacter E. faecalis Citrobacter
13 2016/10/15 21.3 S. epidermidis S. aureus S. epidermidis S. aureus
43 2017/1/10 9.7 E. coli K. pneumoniae E. coli K. pneumoniae
87 2017/1/20 10.5 E. coli K. pneumoniae E. coli K. pneumoniae
105 2017/2/1 27.0 K. pneumoniae S. capitis K. pneumoniae S. capitis
178 2017/4/25 10.3 K. pneumoniae S. pneumoniae K. pneumoniae S. pneumoniae
327 2017/5/25 12.5 E. coli E. faecium E. coli E. faecium
Sequential multiple infections at different times during one hospitalization
9 2016/10/19 9.8 K. pneumoniae – – –
2016/11/2 10.8 E. faecium – E. faecium –
2016/11/7 13.5 P. aeruginosa – P. aeruginosa –
10 2016/11/14 11.3 E. coli – E. coli –
2016/11/18 67.0 C. albicans – C. albicans –
2016/11/19 11.0 A. baumannii – A. baumannii –
82 2016/12/6 11.9 E. coli – E. coli –
2016/12/8 24.7 S. haemolyticus – S. haemolyticus –
91 2017/3/20 14.3 K. pneumoniae – K. pneumoniae –
2017/4/4 10.5 E. coli – E. coli –
94 2017/5/15 12.5 S. aureus – S. aureus –
2017/5/20 24.3 S. capitis – S. capitis –
133 2017/5/19 22.8 E. faecium – E. faecium –
2017/5/25 12.2 A. baumannii – A. baumannii –
176 2017/5/26 69.6 E. coli – E. coli –
2017/5/27 70.2 C. difficile – – –
2017/5/30 34.6 E. avium – – –
334 2017/5/31 36.4 K. pneumoniae – K. pneumoniae –
2017/6/14 12.0 E. coli – E. coli E. faecalis
PCR-MCA, real-time polymerase chain reaction coupled with multiplex probe melting curve analysis.
(cases number 9 and 42) were identified with K. pneumoniae
infection by blood culture, but the results of the PCR-MCA assay
were negative. These two cases both came from surgical wards
and had increased C-reactive protein levels; case No. 42 also
had a decreased white blood cell counts. Six cases (cases number
121, 229, 314, 334, 354, and 355) were identified as having single
infection by blood culture, but the results of the PCR-MCA assay
showed multiplex DNAemia from two pathogens. These six cases
both had increased procalcitonin levels, and cases number 354
and 355 also had increased white blood cell counts, while cases
number 314, 334 and 355 had increased C-reactive protein levels.
The time-to-positivity (TTP) of blood culture was 9.8 h in cases
number 9 and 42, and 13.0, 25.0, 18.3, 12.0, 13.7, 6.5 h in cases
number 121, 229, 314, 334, 354, and 355, respectively. These
discordant results were further confirmed using a uniplex PCR
assay and showed the same results as the PCR-MCA assay.
DISCUSSION
Delayed diagnosis of a pathogenic infection may increase the
mortality rate of fatal sepsis. The earlier specific antibiotic
administration is performed, the better the effect of the treatment
and benefit to the patients (Dellinger et al., 2008). To date,
the routine method for pathogen identification was blood
culture, the whole procedure for which requires more than 2
days to perform and includes blood culture, Gram staining,
plate culture and systematic microbial mass spectrometric
identification. Because of the long duration of blood culture,
empirical antibiotic therapy is administered by necessity (Singer
et al., 2016), enhancing the problem of antibiotic resistance.
In recent years, molecular biological methods have gradually
been applied in pathogen detection in sepsis, reducing the
detection duration while demonstrating excellent diagnostic
performance (Rello et al., 2018).
The present study included 2,763 patients with 2,844
consecutive new episodes of suspected BSIs to evaluate a
PCR-MCA assay for pathogen detection. The most common
pathogen identified by blood culture was E. coli, followed by
K. pneumoniae, S. aureus, S. epidermidis, A. baumannii, P.
aeruginosa, S. pneumoniae, C. albicans, etc. The PCR-MCA
assay could identify 11 kinds of gram-positive bacteria, 12
kinds of gram-negative bacteria, five kinds of fungi and two
types of resistance genes. For the pathogens on the PCR-MCA
list, the PCR-MCA assay discovered 99.2% (239/241) of the
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pathogens discovered by blood culture, with a specificity of 100%
(2,575/2,575) and agreement of 99.9% (2,814/2,816) compared
with the results of blood culture, suggesting that the assay
presented excellent diagnostic performance compared with blood
culture. For all the pathogens tested in clinical practice, the
PCR-MCA assay also presented a good sensitivity of 88.8%
(239/269) with a specificity of 100% (2,575/2,575) and agreement
of 98.9% (2,814/2,844). For some prevalent pathogens, e.g., E.
coli, A. baumannii, P. aeruginosa, S. aureus, S. epidermidis, and
S. pneumoniae, the sensitivity of the PCR-MCA assay could
reach 100%, while the specificity reached over 99%. Notably, for
some samples with multiple pathogens identified simultaneously
during one blood culture investigation, the PCR-MCA assay
verified the results of blood culture, with an agreement rate
of 100% for each. This finding may indicate that the PCR-
MCA assay could be used to obtain early indication of multiple
infections and help clinicians adopt the corresponding treatment
strategy in a timely manner.
Discordance was observed in eight episodes of BSIs from
eight cases. Two of them had negative results in the PCR-MCA
assay but were identified with K. pneumoniae infection by blood
culture. The TTP of both these cases was 9.8 h, much shorter than
the average TTP of K. pneumoniae of 22 h (Ning et al., 2016).
The TTP of an automated continuous blood culture system may
indicate the original concentration of the organism (Da et al.,
2016). It could be inferred that the original concentration of
K. pneumoniae was sufficient, but the failure of the PCR-MCA
assay to detect this organism may be due to the low sensitivity
of this method compared to blood culture for K. pneumoniae
detection. Samples of six other episodes were identified with one
more pathogen than what was identified by blood culture. The
TTP of blood culture of all these samples, which is defined as
the length of time from the beginning of culture incubation to
the detection of bacterial growth by an automated system (Tang
et al., 2017), was ≤25 h. It could be inferred that the pathogen
identified by blood culture was in dominance, which had a
higher initial inoculum concentration or speed of growth, and
its growth competitively inhibited others, known as “Jameson
effect” (Mellefont et al., 2008). Non-dominant pathogens could
also cause BSIs or originate from contamination.
The PCR-MCA assay is more advanced in some aspects than
the existing blood culture techniques. First,<4 h were required to
perform an entire PCR-MCA procedure. Pathogens of suspected
BSIs could be identified within a short time, which will guide
clinicians to adjust antibiotic therapy in a timely manner. In
this way, the mortality of sepsis could be reduced, as well as
the trends of resistance development. Second, the PCR-MCA
assay could detect 28 kinds of pathogens simultaneously, which
could prevent interference by the “Jameson effect” in mixed
infection. In the blood culture process, identification and analysis
of pathogens followed cultivation. When two or more pathogens
are present in one sample, once the growth of dominant
pathogens competitively inhibits others, the results of blood
culture may falsely indicate single infection. Moreover, the PCR-
MCA assay could detect two types of resistance genes, namely,
vanA and mecA, along with pathogen detection, although none
was identified in the present study. Third, the NPV of the
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PCR-MCA assay could reach 100% in detection of 27 kinds
of pathogens on the panel except for K. pneumoniae. Even for
pathogens not on the PCR-MCA list, the NPV reached over
99%. Since a sufficiently high NPV could provide high odds
to exclude uninfected patients, unnecessary empirical antibiotic
therapy could be avoided.
This study has several limitations that need to be addressed.
First, not all of the pathogens that cause BSIs were included in this
assay, and only 88.8% of the prevalent pathogens were identified,
limited by the panel of detectable germs. Additional kinds of
prevalent pathogens should be incorporated into this assay before
clinical application. Second, the number of targeted pathogens,
i.e., Serratia marcescens, Proteus mirabilis, Streptococcus pyogenes,
Listeria monocytogenes, Candida parapsilosis, Candida krusei,
and Aspergillus fumigatus, was insufficient for evaluation of
diagnostic performance. The detection rate of the resistance
genesmecAwas 0, relatively low compared with the data reported
by the China Antimicrobial Surveillance Network (http://www.
chinets.com/), in which the prevalence of methicillin-resistant
Staphylococcus aureus (MRSA) could be as high as 45.8% and
the detection rate of mecA in MRSA could be 93.6% (Chen
et al., 2012). That may be explained by the small number of
MRSA (n = 4) in our study site, as well as the probability
of a mecA-negative strain of Staphylococcus species with high-
level beta-lactam resistance which has been reported (Banerjee
et al., 2010). In addition, no vancomycin-resistant Enterococcus
(VRE) species was identified in phenotypic susceptibility tests,
consistent with the PCR-MCA result showing that the vanA
gene was not detected. According to the China Antimicrobial
Surveillance Network, the prevalence of VRE was 2.3%, and the
detection rate of vanA in VRE could be 73.9% (Zhao et al.,
2012). Larger samples are needed to verify the efficiency and
accuracy of the PCR-MCA assay in future studies. Third, the
resistance genes vanA and mecA included in the PCR-MCA
assay were related to only gram-positive bacteria, so additional
kinds of prevalent resistance genes should be incorporated into
this assay for further study. Finally, samples with discordant
results were further verified using a uniplex PCR assay and
showed the same results as the PCR-MCA assay. Since the uniplex
PCR detection system was built following the same principle
as the PCR-MCA assay, the confirmation results may not be
sufficiently objective, and a third detection method is necessary
for evaluation. In addition, several positive PCR-MCA results
but negative blood culture results were observed in this study,
though the agreement rates of these two assays were high in
general. Cross-reaction with other potential microorganisms in
this assay should be investigated more extensively to promote
clinical application.
In conclusion, our study demonstrated that the PCR-MCA
assay is valuable proof of principle, simultaneously identifying
28 kinds of pathogens and two resistance genes in patients with
suspected BSIs within a few hours. This novel assay exhibited
considerable sensitivity and specificity and covered 88.8% of the
pathogens in clinical practice. Rapid identification of pathogens
involved in BSIs could help clinicians to make the correct
diagnosis and guide antibiotic administration. Furthermore,
additional kinds of prevalent pathogens could be selected to
incorporate into this assay, which could be applied in clinical
practice someday.
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